Bactiguard is a global MedTech company developing safe and biocompatible technology to prevent medical device related infections. The company’s unique technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard’s infection prevention solutions decrease patient suffering, save lives, and unburden healthcare resources while also fighting against antimicrobial resistance, one of the most serious threats to global health and modern medicine.
The company also has a portfolio of wound management products.
Bactiguard operates through license partnerships with leading global MedTech companies that apply the technology to their medical devices and sell them under their own brand or co-branded with Bactiguard.
Bactiguard has a portfolio of coated medical devices which comprises of urinary catheters, endotracheal tubes, and central venous catheters.
Following a strategic review in 2023, the portfolio is currently being discontinued.
Bactiguard’s Wound Management offering includes Hydrocyn aqua (wound care products enabling wound healing and preventing infection) as well as a wide range of surgical sutures.
